Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -457.75% is 133% below its 5-year average of -196.41%, around the middle of its 5-year range (-656.60%–-103.30%).
As of the fiscal period ended Tuesday, June 30, 2026. 60.52% below its 12-month average of -285.16%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -457.75%.
RETURN ON INVESTED CAPITAL (ROIC)
-457.75%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-285.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-277.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-196.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-180.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-180.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-155.58%
CURRENT VS TTM AVG
-60.52%
CURRENT VS 3Y AVG
-65.23%
CURRENT VS 5Y AVG
-133.06%
CURRENT VS 10Y AVG
-153.14%
CURRENT VS 15Y AVG
-153.14%
CURRENT VS 20Y AVG
-194.22%
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-1184.18%
vs the sector median at left
GT Biopharma, Inc.
Market Cap
$8.07M
Return on Invested Capital (ROIC)
-457.75%
TTM Avg
-285.16%
3Y Avg
-277.04%
5Y Avg
-196.41%
Market Cap
$7.93M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-259.12%
3Y Avg
-153.58%
5Y Avg
-167.70%
Market Cap
$8.10M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-174.21%
3Y Avg
-638.36%
5Y Avg
-516.05%
Market Cap
$8.38M
Return on Invested Capital (ROIC)
-21.90%
TTM Avg
-47.33%
3Y Avg
-176.82%
5Y Avg
-106.87%
Market Cap
$7.86M
Return on Invested Capital (ROIC)
-92.93%
TTM Avg
-227.52%
3Y Avg
-201.78%
5Y Avg
-175.64%
Market Cap
$7.86M
Return on Invested Capital (ROIC)
-33.73%
TTM Avg
-84.97%
3Y Avg
-168.83%
5Y Avg
-136.52%
Market Cap
$7.75M
Return on Invested Capital (ROIC)
-92.94%
TTM Avg
-279.36%
3Y Avg
-244.50%
5Y Avg
-201.18%
Market Cap
$8.45M
Return on Invested Capital (ROIC)
-439.90%
TTM Avg
-355.30%
3Y Avg
-355.30%
5Y Avg
-355.30%
Market Cap
$7.64M
Return on Invested Capital (ROIC)
-107.08%
TTM Avg
-63.63%
3Y Avg
-49.78%
5Y Avg
-53.46%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | $8.07M | -457.75% | -285.16% | -277.04% | -196.41% |
| Traws Pharma, Inc. (TRAW)vs › | $7.93M | N/A | -259.12% | -153.58% | -167.70% |
| HeartSciences Inc. (HSCS)vs › | $8.10M | N/A | -174.21% | -638.36% | -516.05% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.38M | -21.90% | -47.33% | -176.82% | -106.87% |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.86M | -92.93% | -227.52% | -201.78% | -175.64% |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.86M | -33.73% | -84.97% | -168.83% | -136.52% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | -92.94% | -279.36% | -244.50% | -201.18% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.45M | -439.90% | -355.30% | -355.30% | -355.30% |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.64M | -107.08% | -63.63% | -49.78% | -53.46% |
| Skye Bioscience, Inc. (SKYE)vs › | $7.53M | N/A | -166.69% | -591.28% | -439.14% |
ROIC
-457.7%
ROE
-618.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -457.75% |
| 2026-03-31 | -175.96% |
| 2025-12-31 | -214.65% |
| 2025-09-30 | -353.00% |
| 2025-06-30 | -224.46% |
| 2024-09-30 | -656.60% |
| 2024-06-30 | -241.23% |
| 2024-03-31 | -244.77% |
| 2023-12-31 | -181.59% |
| 2023-09-30 | -146.37% |
| 2023-06-30 | -151.02% |
| 2023-03-31 | -121.67% |
| 2022-12-31 | -180.17% |
| 2022-09-30 | -209.75% |
| 2022-06-30 | -209.43% |
| 2022-03-31 | -189.31% |
| 2021-12-31 | -262.13% |
| 2021-09-30 | -130.15% |
| 2021-06-30 | -103.30% |
| 2021-03-31 | -144.28% |
| 2019-06-30 | -1152.60% |
| 2019-03-31 | -1157.07% |
| 2018-12-31 | -1127.76% |
| 2018-09-30 | -1056.21% |
| 2018-06-30 | -57.35% |
| 2018-03-31 | -55.32% |
| 2017-12-31 | -53.86% |
| 2017-09-30 | -51.43% |
| 2008-03-31 | -69.55% |
| 2007-12-31 | -58.20% |
| 2007-09-30 | -70.88% |
| 2007-06-30 | -112.03% |
| 2006-12-31 | -76.48% |
| 2006-09-30 | -62.96% |
| 2006-06-30 | -58.28% |
| 2006-03-31 | -52.52% |
| 2005-12-31 | -48.03% |
| 2005-09-30 | -25.59% |
| 2005-06-30 | -15.28% |
| 2005-03-31 | -21.84% |
| 2004-12-31 | -20.35% |
| 2004-09-30 | -88.45% |
| 2004-06-30 | -117.67% |
| 2004-03-31 | -93.16% |
| 2003-12-31 | -75.05% |
| 2003-09-30 | -63.03% |
| 2003-06-30 | -84.63% |
